Relay Therapeutics Inc
NASDAQ:RLAY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Relay Therapeutics Inc (RLAY) under the Base Case is USD per share.
Compared with the current market price of 19.72 USD, the stock appears .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Relay Therapeutics Does
Relay Therapeutics is a drug discovery company that builds cancer medicines by studying how proteins move and change shape. Instead of searching for drugs in a broad, trial-and-error way, it uses structural biology and computation to find weak spots in disease-driving proteins and design small-molecule drugs that fit those targets more precisely.
- Headquarters
- United States of America US
- Employees
- 192
- IPO date
- Jul 16, 2020
Earnings Waterfall
Relay Therapeutics Inc
What is the Intrinsic Value of one RLAY stock?
The intrinsic value for Relay Therapeutics Inc (RLAY) under the Base Case is USD.
Is RLAY stock undervalued or overvalued?
Compared with the current market price of 19.72 USD, the stock appears .
